Streetbeat News

Products Services

CANF

Can-Fite BioPharma's study on Namodenoson's inhibition of pancreatic carcinoma has been published in the Journal of Clinical Oncology supplement of the 2023 ASCO Annual Meeting Proceedings. The company focuses on developing small molecule drugs for oncology, inflammatory, and liver diseases.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 11:02 am

BMY

The FDA has accepted Bristol Myers Squibb's New Drug Application for repotrectinib, a treatment for ROS1-positive non-small cell lung cancer, granting it Priority Review with a PDUFA goal date of November 27, 2023.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 11:00 am

PFE

Pfizer announced positive results from its Phase 3 BASIS clinical trial for marstacimab, a treatment for hemophilia A and B. The study demonstrated a statistically significant reduction in annualized bleeding rate compared to prophylaxis and on-demand intravenous regimens.

Portfolio Pulse from Charles Gross

May 30, 2023 | 10:48 am

SWTX

SpringWorks Therapeutics has fully enrolled its Phase 2 trial evaluating Nirogacestat in patients with ovarian granulosa cell tumors (OvGCT). Initial data from the trial is expected to be reported in 2024. OvGCT accounts for 5% of all ovarian cancers and 70% of ovarian sex cord tumors.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 10:33 am

TIGR

UP Fintech Holding Ltd (TIGR) reported Q1 FY23 revenue growth of 26% YoY to $66.33 million, beating the consensus of $45.06 million. The company added 30,392 funded accounts in the quarter and soft-launched TigerGPT, a financial AI based on ChatGPT.

Portfolio Pulse from Anusuya Lahiri

May 30, 2023 | 10:25 am

VCNX

Vaccinex and H. Lee Moffitt Cancer Center and Research Institute have been granted U.S. Patent #11660330 for combination therapy with semaphorin-4D blockade (SEMA4D) and DC1 therapy. This patent could potentially lead to advancements in cancer treatment.

Portfolio Pulse from Charles Gross

May 30, 2023 | 10:13 am

IMRN

Immuron has received approval from the U.S. Army Medical Research and Development Command to proceed with its planned clinical trial in the United States and has begun recruitment for the Travelan study.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 10:06 am

TSLA

Tesla has been granted two U.S. patents, one for seatbelt usage detection and another for a QoS manager for system on a chip communications.

Portfolio Pulse from Charles Gross

May 30, 2023 | 9:58 am

NVDA

Nvidia shares rose 4% premarket after announcing it is building Israel's most powerful AI supercomputer. The project aims to advance AI research and development in the country.

Portfolio Pulse from Charles Gross

May 30, 2023 | 9:27 am

BHP

MSFT

BHP and Microsoft have collaborated to use artificial intelligence and machine learning to improve copper recovery at the world's largest copper mine, Escondida in Chile. The new digital technology is expected to optimize concentrator performance and generate more value from the existing resource.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 9:21 am